Vetoquinol - Universal Registration Document - 2021

CONSOLIDATED FINANCIAL STATEMENTS Notes to the consolidated financial statements 78 Vetoquinol Universal Registration Document 2020 Financial report 6 6.5.8.3 2019 operating segment results €000 By asset location Europe Americas Asia/Pacific (rest of world) Consolidated total Sales 292,386 163,707 37,501 493,595 Inter-segment sales (81,631) (15,906) (68) (97,605) Total external sales 210,756 147,801 37,433 395,990 EBIT 27,863 14,482 3,559 45,903 Non-recurring operating income and expenses (5,018) 0 - (5,018) Operating income 22,845 14,482 3,559 40,886 Net financial income/(expense) (205) - - 361 Income before tax 40,681 - - 48,581 Income tax (12,464) - - (12,171) Income after tax 28,217 - - 36,411 Earnings/(loss) of associates 30 - - (185) CONSOLIDATED NET INCOME 28,247 Tracking by destination region or end market (per region). €000 By geographical region Europe Americas Asia/Pacific (rest of world) Consolidated total Sales 248,861 173,191 71,543 493,595 Inter-segment sales (61,979) (27,681) (7,945) (97,605) TOTAL EXTERNAL SALES 186,882 145,511 63,598 395,990 The Group also tracks sales by species. €000 By species Pets Food-producing animals Consolidated total Sales 291,539 202,056 493,595 Inter-segment sales (65,269) (32,336) (97,605) TOTAL EXTERNAL SALES 226,270 169,720 395,990